Latest filing published 30 Apr 2021 for Croda International Plc, €273k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Maarten Willem Heijbroek: trading record in brief
Maarten Willem Heijbroek appears in our data through filings on Croda International PLC shares, published by RNS (LSE). Over a trading history stretching from 30 April 2013 to 30 April 2021, the count stands at 14 filings.
The open-market side counts 1 purchase for €26k alongside 11 sales for €6.2M. On balance, insiders were net sellers of €6.2M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants. Since January 2021: no purchases and 2 sales on the market.
The latest filing, published on 30 April 2021, reports an open-market sale of €273k in Croda International PLC. The latest purchase dates back some time: it was published 4,940 days ago, on 1 May 2013. The median gap between a trade and its publication by RNS (LSE) is 1 day. The regulation allows three business days to notify a trade (UK MAR). Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Maarten Willem Heijbroek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,500 shares@ £67.72351.4% of flowXLONISIN GB00BJFFLV09FCA-NSM:3961225
- 6,368 shares@ £149.295317.9% of flowXLONISIN GB00BJFFLV09FCA-NSM:3914521
- 1,991 shares@ £49.030.7% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20190328111314_14019580_20200326185132917_2420
- 2,518 shares@ £48.4390.9% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20190312142227_13999424_20200326185134073_19121
- 943 shares@ £48.290.3% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20190311141659_13997688_20200326185134150_20730
- 17,055 shares@ £117.550137.6% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20190306100230_13992179_20200326185134386_25873
- 2,000 shares@ £48.302.5% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20181114082418_13866367_20200330111438602_17658
- 1,020 shares@ £0.020.0% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180419094749_13610835_20200330111352832_9749
- 1,502 shares@ £46.451.2% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180312140339_13563605_20200330111427641_20189
- 15,216 shares@ £78.242721.5% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20180308111752_13559889_20200330111427784_23214
- 7,004 shares@ £76.654410.3% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20170515172309_13226137_20200330131531019_11714
- 579 shares@ £33.40120.4% of flowXLONISIN GB00BYZWX769FCA-NSM:LSE20160805152831_012921672_20200330143543850_5694
- 106 shares@ £20.655FCA-NSM:LSE20141002144353_012104067_20200330172032867_1586-3
- 883 shares@ £24.6297FCA-NSM:LSE20130501163003_011569777_20200330164711774-1Canonical exit: 29 Jul 2013 (T+90)
14 of 14 declarations